Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, CSL commits to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
The CSL Seqirus site in Tullamarine, Melbourne, will be capable of supplying Australia with cell-based flu vaccine and meetin…
Dr Marios Koutsakos announced as the winner of the European Scientific Working Group on Influenza (ESWI) Early Career Scienti…
For its full-scale use of robotics and automation technologies, the Australian manufacturing site received the Facility of th…
We explain this term in pharmaceutical manufacturing. Fill-finish occurs before a product leaves the manufacturer.
A first-of-its kind program created by Wake Tech Community College aims to meet the biopharmaceutical sector’s need for skill…
We’re addressing unmet medical needs through new research partnerships with eight world-class researchers.
At the event for industry leaders, President Emmanuel Macron positioned France as a global innovator ready to partner with co…
CSL, one of Jumar’s founding partners, celebrated the launch of the state-of-the-art facility, designed to help early-stage b…
Lab automation is helping CSL R&D scientific staff to generate and process data more quickly, enhance reproducibility and be …
CSL has extended its partnership with BaseLaunch, a Basel-area biotech accelerator and incubator for therapeutic ventures.
For its Kankakee location, where rare disease medicines are manufactured, CSL Behring was honored for innovation and operatio…
CSL’s Ian Njoroge, based at CSL’s Kankakee, Illinois, manufacturing site, headed up a team that took first place at Chicago’s…
Americas
Asia Pacific
Middle East
Europe
